Ligand Pharmaceuticals Inc (LGND)
R&D Expense Growth
278.91%
Fiscal year · Period ending:
LGND R&D Expense Growth
Latest reported278.91%period ending
Latest reported278.91%period ending
LGND FY R&D Growth (YoY) (0.00% → 278.91%)
Latest values, visible window
High-resolution chart · PNG
LGND r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 278.9125% | |
| -12.6829% | |
| -31.9966% | |
| 12.3875% | |
| -20.7343% | |
| -27.5542% | |
| 100.6532% | |
| 3.63% | |
| 26.7% | |
| 58.6024% | |
| 10.3778% | |
| 30.7095% | |
| -14.05% | |
| 4.8489% | |
| -53.3648% | |
| -44.6526% | |
| 29.5743% | |
| -31.0445% | |
| 6.4328% | |
| -25.2323% | |
| -14.0007% | |
| -3.657% | |
| 15.0866% | |
| 15.0732% | |
| -0.3568% | |
| -13.6582% | |
| -15.983% | |
| -2.3481% | |
| 21.6807% | |
| 43.7198% | |
| 0% | |
| 0% |